Human Growth Hormone Market 2027 Size, Share, Trends, Growth, Regional Outlook And Forecast to 2027

Human somatotropin may be a protein hormone that promotes cellular growth, reproduction, and cell differentiation in humans and lots of other animals. it’s therefore vital in human growth. It helps maintain the traditional functioning of the reproductive organs, controls blood heat , orchestrates cellular division , orchestrates the event of the systema nervosum , governs vital sign , and helps maintain the skin’s elasticity. It also has effects on other body tissues like the eyes, liver, pancreas, kidneys, stomach, and adrenal glands.

The PDF for the study can be requested using the following link:

Market Dynamics

High prevalence of chronic GH deficiency is predicted to spice up growth of the worldwide human somatotropin market. as an example , consistent with the study, “Prevalence of somatotropin deficiency in middle-age adults recovering from stroke”, published within the journal Brain Injury, in October 2019, GHD was diagnosed in 54% of patients, with 32% falling into the severe category.

Moreover, approval and launch of latest products is additionally expected to assist in growth of the market. as an example , in September 2020, The US Food and Drug Administration approved somapacitan (Sogroya, Novo Nordisk) for the replacement of endogenous somatotropin |hormone|endocrine|internal secretion”> somatotropin in adults with growth hormone deficiency.

However, skepticism about over-the-counter human somatotropin |hormone|endocrine|internal secretion”> somatotropin claims is predicted to hinder growth of the worldwide human growth hormone market. Use of somatotropin therapy in children also increases the danger of cardiovascular diseases in adulthood. Such side effects also are expected to limit the market growth.

Among regions, Asia Pacific is predicted to witness significant growth within the global human somatotropin market, due to approval and launch of latest products within the region. as an example , in August 2020, I-Mab, a clinical stage biopharmaceutical company, announced that the China National Medical Products Administration has accepted its pivotal trial application for eftansomatropin (also referred to as TJ101) as a weekly treatment for somatotropin deficiency in pediatric patients.

Competitive Analysis

Major players operating within the global human somatotropin market include, Pfizer Inc., Genetech Inc., Merck & Co., Eli Lilly And Company, OPKO Health Inc., Novo Nordisk, Sandoz International GmbH, Ferring Holding SA, and Ipsen.

Major players operating within the global human somatotropin market are focused on R&D to expand their product portfolio. as an example , in October 2019, OPKO Health Inc. announced that the worldwide Phase 3 trial evaluating somatrogon dosed once-weekly in pre-pubertal children with somatotropin deficiency (GHD) met its primary endpoint of non-inferiority to daily GENOTROPIN (somatropin) for injection, as measured by annual height velocity at 12 months.

“Limited Time Offer”

We also offer 15% FREE Report customization.
Get This premium report with Instant US$ 2000 discount @

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027


About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformation growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Related Articles

Back to top button